Sign in

CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company

BriaCell Therapeutics Corp.

Sign in to watch
Ticker
BCTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jul 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 921-1810
Business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
Former names
Ansell Capital Corp.

Securities

  • BCTX Common Shares Nasdaq
  • BCTXL Warrants Nasdaq
  • BCTXZ Warrant Nasdaq
  1. EFFECT Other Notice of Effectiveness
  2. POS AM Other Post-effective Amendment for Registration Statement
  3. 6-K Event Report of Foreign Issuer
  4. 40-F/A Report 40-F/A
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 40-F Report 40-F
  9. 6-K Event Report of Foreign Issuer
  10. 424B3 Offering Prospectus
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. SC 13D/A Stake Beneficial Ownership Report
  14. SC 13G Stake Amended Statement of Ownership
  15. 6-K Event Report of Foreign Issuer
  16. SC 13D Stake Beneficial Ownership Report
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. SC 13G Stake Amended Statement of Ownership

Page 12 of 17 · 324 filings